Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as
Case Western Reserve´s new vice president for research, effective this month.
Rivera, the university´s associate vice president for research since January 2011,
emerged as the top choice after an extensive process involving campuswide nominations
of internal university candidates. Since coming to CWRU, Rivera has distinguished herself
through a commitment to collaboration and a focus on systems and processes.
Read more about her.
Click here to view previous editions of Research Matters and Research News and Updates.
December 9, 2014
The Cleveland Area Reliant IRB Review Process
The Cleveland Area Reliant Institutional Review Board (IRB) Review process includes participation by the Case Western Reserve University (CWRU) Social, Behavioral, and Educational Research (SBER) IRB, the Cleveland Clinic (CC) IRB, MetroHealth Medical Center (MHMC) IRB, and University Hospitals Case Medical Center (UHCMC) IRB. The process relies on executed IRB Authorization Agreements (IAA) between the institutions. These agreements document that all applicable human research subjects protection considerations will be made by one Institutional Review Board (IRB), which will be deemed the IRB of record. The IRBs of the other Cleveland area institutions will accept the approval of the IRB of record through the Reliant Review process. The goal is to eliminate duplication of effort and multiple applications for submission of the same protocol, and to encourage scientific collaboration among the affiliated institutions.
What types of studies are eligible for the Reliant Review Process?
Any type of human research study could be eligible for the Reliant Review process. These include but are not limited to investigator-initiated, federally-funded, foundation-supported, industry-sponsored, and non-funded studies.
The fundamental requirement is that a collaborating investigator must be named at each site where the research will occur. It is important for the Principal Investigator at the lead study site to work with the IRB of record throughout the Reliant Review Process to initiate acceptance of IRB approval at each collaborating site.
For further information, contact Kim Volarcik at (216) 368-0134 or email@example.com.
CWRU researchers who receive requests for information that invoke the Freedom of Information Act (FOIA) should contact the Office of General Counsel. This should be done immediately so the extremely short deadlines under FOIA can be met. General Counsel can work with the faculty member to take steps to protect proprietary or confidential information from grants and protocols prior to the release of the requested information. Individual researchers should not release information without first consulting with the CWRU Office of General Counsel.
Opening date: October 1, 2014 Closing date: September 30, 2015 Pre-Proposals:Applicants are encouraged to submit their Pre-Proposals as early as possible in the fiscal year as funding is based on availability Invitation to Submit: within 120 days of pre-proposal submission Full Proposals: submitted within 90 days of the invitation Notice of Awards: within 180 days of submission Funding: Budgets are not capped and must reflect the scope of the work. Funding can be requested for up to 5 years.
Programs of interest:
1. Military Infectious Diseases Research
2. Combat Casualty Care Research
3. Military Operational Medicine Research
4. Clinical and Rehabilitative Medicine Research
5. Medical Biological Defense Research
6. Medical Chemical Defense Research
7. Medical Training and Health Information Sciences
8. Radiation Health Effects Research
9. Special Investment Areas
Office of Strategic Initiatives (OSI): CWRU School of Medicine's OSI can work with you to make sure that you meet the current goals and objectives of the USAMRMC. Contact OSI: Irene Shaland - firstname.lastname@example.org - 216.368.4970.
Case Comprehensive Cancer Center
All Faculty members are invited to submit concept proposals for 5 year Projects to compete for incorporation as a full project proposal in the upcoming GI SPORE competing renewal application that will be prepared starting in January 2015 for submission in September 2015 All proposals must be directed towards translational research of a GI malignancy, with at least one specific aim that involves direct study of patients or of human tissues.
Proposals must include two project leaders; one Basic Science leader and one Clinical leader. Maximum Funding Level – $185,000/year direct cost for 5 years ($925,000 total direct costs).
Completed proposals must be emailed to John Pounardjian, email@example.com. For more information on GI SPORE, visit the CaseCCC website.
Department of Defense
The Department of Defense has announced the following new funding opportunities:
If you have news or information that you wish to have included in this
update, please send it via e-mail to Tracy Wilson-Holden at
firstname.lastname@example.org no later than
5 pm on the Monday of the week that the update is to be distributed. If you
know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe
to Case Research News, email your request to Tora Williams at
Please note: At the time of this transmission, all links functioned.
However, Case Research News cannot guarantee that the information will not move or be